These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

505 related items for PubMed ID: 11465424

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Release of testosterone from an osmotic pump tablet utilizing (SBE)7m-beta-cyclodextrin as both a solubilizing and an osmotic pump agent.
    Okimoto K, Rajewski RA, Stella VJ.
    J Control Release; 1999 Mar 08; 58(1):29-38. PubMed ID: 10021487
    [Abstract] [Full Text] [Related]

  • 4. Improvement of some pharmaceutical properties of DY-9760e by sulfobutyl ether beta-cyclodextrin.
    Nagase Y, Hirata M, Wada K, Arima H, Hirayama F, Irie T, Kikuchi M, Uekama K.
    Int J Pharm; 2001 Oct 23; 229(1-2):163-72. PubMed ID: 11604269
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Study on the supramolecular system of meso-tetrakis (4-sulfonatophenyl) porphyrin and cyclodextrins by spectroscopy.
    Wang XP, Pan JH, Shuang SM.
    Spectrochim Acta A Mol Biomol Spectrosc; 2001 Dec 23; 57(14):2755-62. PubMed ID: 11789876
    [Abstract] [Full Text] [Related]

  • 9. Effect of alkyl chain length and degree of substitution on the complexation of sulfoalkyl ether beta-cyclodextrins with steroids.
    Zia V, Rajewski RA, Bornancini ER, Luna EA, Stella VJ.
    J Pharm Sci; 1997 Feb 23; 86(2):220-4. PubMed ID: 9040099
    [Abstract] [Full Text] [Related]

  • 10. Thermodynamics of binding of neutral molecules to sulfobutyl ether beta-cyclodextrins (SBE-beta-CDs): the effect of total degree of substitution.
    Zia V, Rajewski RA, Stella VJ.
    Pharm Res; 2000 Aug 23; 17(8):936-41. PubMed ID: 11028938
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Preparation and in-vitro release rate of fentanyl-cyclodextrin complexes for prolonged action in epidural analgesia.
    Holvoet C, Plaizier-Vercammen J, Vander Heyden Y, Gabriëls M, Camu F.
    Int J Pharm; 2003 Oct 20; 265(1-2):13-26. PubMed ID: 14522114
    [Abstract] [Full Text] [Related]

  • 15. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
    Suihko E, Korhonen O, Järvinen T, Ketolainen J, Jarho P, Laine E, Paronen P.
    Int J Pharm; 2001 Mar 14; 215(1-2):137-45. PubMed ID: 11250099
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
    Spamer E, Müller DG, Wessels PL, Venter JP.
    Eur J Pharm Sci; 2002 Sep 14; 16(4-5):247-53. PubMed ID: 12208454
    [Abstract] [Full Text] [Related]

  • 20. Assessment of solid-state interactions of naproxen with amorphous cyclodextrin derivatives by DSC.
    Bettinetti GP, Sorrenti M, Rossi S, Ferrari F, Mura P, Faucci MT.
    J Pharm Biomed Anal; 2002 Nov 07; 30(4):1173-9. PubMed ID: 12408907
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.